Navigation Links
K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market
Date:9/10/2010

n Note 18 – "Commitments and Contingencies – Litigation and Governmental Inquiries" of the Notes to the Consolidated Financial Statements in the Form 10-Q;
  • the possibility that insurance proceeds are insufficient to cover potential losses that may arise from litigation, including with respect to product liability, failure to supply or securities litigation;
  • the informal inquiry initiated by the SEC and any related or additional government investigation or enforcement proceedings as more fully described in Note 18 – "Commitments and Contingencies – Litigation and Government Inquiries, of the Notes to the Consolidated Financial Statements" in the Form 10-Q;
  • the possibility that the pending investigation by the Office of Inspector General of the Department of Health and Human Services into potential false claims under the Title 42 of the U.S. Code as more fully described in Note 18 – "Commitments and Contingencies – Litigation and Government Inquiries" of the Notes to the Consolidated Financial Statements in the Form 10-Q could result in significant civil fines or penalties, including exclusion from participation in federal healthcare programs such as Medicare and Medicaid;
  • delays in returning, or failure to return, certain or many of the Company's approved products to the market, including loss of market share as a result of the suspension of shipments, and related costs;
  • the ability to sell or license certain assets, and the terms of such transactions;
  • the possibility that default on one type or class of the Company's indebtedness could result in cross default under, and the acceleration of, its other indebtedness;
  • the risks that present or future changes in the Board of Directors or management may lead to an acceleration of the Company's bonds or to adverse actions by government agencies or our auditors;
  • if a director of our company, or a shareholder with an ownersh
    '/>"/>

  • SOURCE K-V Pharmaceutical Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/17/2014)... 2014   InnFocus, Inc ., reported on results of ... for up to 3 years with the InnFocus ... Chicago . The Summit ... meeting of the American Academy of Ophthalmology . The ... glaucoma patients in 6 countries by early 2015. ...
    (Date:10/17/2014)... 2014  China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... received approval from the China Food and Drug ... prothrombin complex concentrate ("PCC") at its Shandong Taibang ... factor production facility for Good Manufacturing Practices ("GMP") ...
    (Date:10/17/2014)... --  DaVita HealthCare Partners Inc. (NYSE: ... and most innovative health care communities, recently held ... award-winning, leadership development and cultural orientation program for ... the globe were in attendance for the event. ... two-day one-of-a-kind experience for new and recently hired ...
    Breaking Medicine Technology:InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 3
    ... The American Association for Homecare supports tough anti-fraud ... and Commerce subcommittee hearing on this issue this week ... taxpayer dollars. The American Association for Homecare represents providers ... We have zero tolerance for fraud and ...
    ... Sept. 22 NewBridge Pharmaceuticals announced that it has ... AB (STO: ORX) that grants NewBridge rights to seek ... cancer pain, in the Middle East and Africa and, ... product in these territories.  The agreement covers 64 countries ...
    Cached Medicine Technology:Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 2Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 3Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 4Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 5Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 6Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 7NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 2NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 3NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 4
    (Date:10/19/2014)... 20, 2014 The leading review ... http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the best Dedicated ... for those who want to buy high quality ... , The IT manager of Top10BestSEOHosting.com says, “We ... recommended suppliers for everyone. A lot of the ...
    (Date:10/19/2014)... Dallas, Texas (PRWEB) October 20, 2014 ... therapeutic development for Partial Seizure, complete with comparative ... target, mechanism of action (MoA), route of administration ... and featured news and press releases. It also ... for Partial Seizure and special features on late-stage ...
    (Date:10/19/2014)... 20, 2014 Recently, Fancyflyingfox.com, an innovative ... clothes, has announced its latest designs of 2014 ... the new elegant outfits are offered with big discounts, ... order before October 30 can enjoy this special offer. ... marketing strategies, it has become one of the leading ...
    (Date:10/19/2014)... Stephen T. Greenberg, M.D., with offices in Woodbury, Southampton and ... as one of Long Island’s best cosmetic surgeons. In ... the best provider for Botox injections. Glisten, his Skin & ... best Laser Treatment center on Long Island.* , The voting ... the contest once per day, per IP address. , Stephen ...
    (Date:10/19/2014)... 2014 – The U.S. Government has initiated a ... disease by 2025. However, a workgroup of nearly ... milestones in the U.S. Government,s National Plan to ... increased in scale, and adequately funded in order ... proposals by the workgroup to enlarge and strengthen ...
    Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 3Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 4Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 5Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 6
    ... Reinberg HealthDay Reporter , MONDAY, Nov. 14 (HealthDay ... needed medications if they,re free, U.S. researchers find. Less ... their prescribed medications, which increases hospitalizations, deaths and costs to ... if eliminating the co-pay fee might entice more patients to ...
    ... may be making premature predictions about which patients are ... even withdrawing care -- before the window in which ... likely to wake up, according to two new studies ... of Pennsylvania. The research helps to better define the ...
    ... Women with the deadliest and rarest form of breast cancer ... were severely limited, thanks to a new discovery by George ... called "inflammatory breast cancer," kills about half the women who ... mere 18 months after diagnosis. About 10,000 women are diagnosed ...
    ... Scientists presented new research today demonstrating the impact life ... examine how such environmental information can be transmitted from ... as epigenetics. This new knowledge could ultimately improve understanding ... how a parent,s exposure to drugs, alcohol, and stress ...
    ... of therapeutic hypothermia and delay in return of spontaneous ... measurable blood pressure, were both associated with poor neurologic ... study being presented Nov. 14 at the at the ... Also, caregivers who have an appropriate understanding of the ...
    ... Reporter , SUNDAY, Nov. 13 (HealthDay News) -- Tragic stories ... on the playing field due to an undetected heart problem. ... aimed at helping doctors and coaches detect these problems early ... suggests that only a small percentage of physicians are heeding ...
    Cached Medicine News:Health News:More Heart Attack Patients Take Meds When They Are Free 2Health News:More Heart Attack Patients Take Meds When They Are Free 3Health News:Withdrawal of care may occur too soon in cardiac arrest patients who receive hypothermia treatment 2Health News:Withdrawal of care may occur too soon in cardiac arrest patients who receive hypothermia treatment 3Health News:George Mason University research gives hope to women with deadliest breast cancer 2Health News:George Mason University research gives hope to women with deadliest breast cancer 3Health News:Nature and nurture work together to shape the brain 2Health News:Better understanding of neurologic defects improves post-cardiac-arrest discharge 2Health News:Too Few Doctors Screen Young Athletes for Hidden Heart Trouble 2Health News:Too Few Doctors Screen Young Athletes for Hidden Heart Trouble 3
    ... of guiding introducers includes Swartz™ Series, ... piece steerable, all designed for the ... varying curves and longer sheath lengths ... Jude Medical guiding introducers are designed ...
    Lumenis 1000 Integrated Slit Lamp Fully-integrated biomicroscope slit lamp laser delivery system, complete with built-in LaserLink, parallel optics, magnification changer, micromanipulator and multi...
    Novus 30001 A fully-integrated and powerful 532 nm Operating Room Photocoagulator with reliable DPSS technology and simplified operation using a touch screen interface and remote control....
    ... Selecta Trio The pinnacle ... Nd:YAG, diode-pumped solid-state (DPSS) 532 ... laser (SLT) and offering maximum ... The first and only Nd:YAG, ...
    Medicine Products: